Stay updated on Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Pembrolizumab in RCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status now shows that no further participants are being sought, indicating the study has finished enrollment. The page also adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment labeling.SummaryDifference0.4%

- Check17 days agoChange DetectedThe page's revision label was updated to v3.5.5, replacing the previous v3.5.4, indicating a minor update to the page template or documentation.SummaryDifference0.1%

- Check39 days agoChange DetectedThe Revision label on the page changed from v3.5.3 to v3.5.4, indicating a newer page version of the study listing rather than a change to the study details.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page’s display/release revision label was updated from v3.5.2 to v3.5.3, indicating a minor tooling or website update rather than a change to the study record information.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be an internal build update and does not change visible content on the page.SummaryDifference0.1%

- Check96 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.